Evaluation of a new E-test® method for antimicrobial sensitivity testing of Pseudomonas aeruginosa isolates from cystic fibrosis;Étude multicentrique portant sur l'évaluation d'une méthode simplifiée d'analyse bactériologique dans la surveillance des infections bronchiques à Pseudomonas aeruginosa survenant au cours de la mucoviscidose

Pathologie Biologie

Volumn 53, Issue 8-9, 2005, Pages 490-494

  Zebouh, M ^a   Thomas, C ^a   Honderlick, P ^b   Lemee, L ^c   Segonds, C ^d   Wallet, F ^a   Husson, M O ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b FOCH HOSPITAL   (France)

^c HÔPITAL CHARLES NICOLLE   (France)

^d CHU RANGUEIL   (France)

Author keywords

Cystic fibrosis; Direct sputum antimicrobial testing; E test ; Pseudomonas aeruginosa; Sputum

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; CEFTAZIDIME; CIPROFLOXACIN; IMIPENEM; TICARCILLIN; TOBRAMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATION; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG INHIBITION; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; INFORMATION PROCESSING; INOCULATION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PATHOGENICITY; PSEUDOMONAS AERUGINOSA; SPUTUM ANALYSIS; ADULT; BACTERIUM; CHILD; CLASSIFICATION; DRUG EFFECT; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIA; CHILD; CYSTIC FIBROSIS; HUMANS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA;

EID: 27444432707     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2005.06.012     Document Type: Article

References (9)

1. G. Steinkamp, B. Wiedemann, E. Rietschel, A. Krahl, J. Gielen, H. Barmeier Emerging Bacteria Study Group Prospective evaluation of emerging bacteria in cystic fibrosis J. Cyst. Fibros. 4 2005 41 48
2. R.L. Gibson, J.L. Burns, and B.W. Ramsey Pathophysiology and management of pulmonary infections in cystic fibrosis Am. J. Respir. Crit. Care Med. 168 2003 918 951
3. S. Rajan, and L. Saiman Pulmonary infections in patients with cystic fibrosis Semin. Respir. Infect. 17 2002 47 56
4. J.M. Van Dalfsen, J.R. Stapp, C. Phelps, P. Stewart, and J.L. Burns Comparison of two culture methods for detection of tobramycin-resistant Gram negative organisms in the sputum of patients with cystic fibrosis J. Clin. Microbiol. 40 2002 26 30
5. D.A. Heenry, M.E. Campbell, J.J. LiPuma, and D.P. Speert Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium J. Clin. Microbiol. 35 1997 614 619
6. E. Ugolotti, M.L. Belli, and M.L. Fenu Evaluation of a new selective medium for recovery B. cepacia complex, S. maltophilia, A. xylosoxidans and other tobramycin-resistant organisms in the airways specimens of cystic fibrosis patients J. Cystic. fibrosis 1 2002 P192
7. C.H. Goss, N. Mayer-Hamblett, M.L. Aitken, G.D. Rubenfeld, and B.W. Ramsey Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis Thorax 59 2004 955 959
8. e édition.
9. Comité de l'antibiogramme de la Société française de microbiologie. Communiqué 2005.